Pharmaceutical Executive February 23, 2021
How can pharmaceutical companies successfully apply advanced analytics? Pricing experts from Simon-Kucher & Partners identify the hurdles and winning approaches.
In recent years, a continuous increase in budgetary payer pressure and development of payer management tools have significantly impacted market access and pricing opportunities for innovative pharmaceuticals. More and more firms are struggling to achieve price premiums and justified prices, even for drugs that are more innovative than and clinically superior to competitor drugs. The key issue is the limited ability to increase a drug’s price once it has been negotiated and set in a specific market. It is therefore crucial to launch at a price that represents the true value to patients and the healthcare system.